Cyclobarbital: Difference between revisions

Jump to navigation Jump to search
m (Protected "Cyclobarbital": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Drugbox|
{{Drugbox
|IUPAC_name = ''5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione''
| Verifiedfields = changed
| image = Cyclobarbital.svg
| Watchedfields = changed
| width=100
| verifiedrevid = 460109682
| CAS_number=52-31-3
| IUPAC_name = ''5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione''
| ATC_prefix=N05
| image = Cyclobarbital.png
| ATC_suffix=CA10
| width = 100
| ATC_supplemental=
| image2 = Cyclobarbital2.png
| PubChem=5838
| width2 = 180
| DrugBank=
 
| C=12 | H=16 | N=2 | O=3
<!--Clinical data-->
| molecular_weight = 236.267
| Drugs.com = {{Drugs.com|international|cyclobarbital}}
| bioavailability= ?
| tradename =
| pregnancy_category =  
| legal_status =  
| routes_of_administration = Oral
 
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism = [[Hepatic]]
| metabolism = [[Hepatic]]
| elimination_half-life= ?
| elimination_half-life =  
| excretion = [[Renal]]
| excretion = [[Renal]]
| pregnancy_category = ?
 
| legal_status = ?
<!--Identifiers-->
| routes_of_administration= Oral
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 143-76-0
| ATC_prefix = N05
| ATC_suffix = CA10
| PubChem = 5838
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5632
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0M8A98AD9H
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07323
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 268164
 
<!--Chemical data-->
| C=12 | H=16 | N=2 | O=3
| molecular_weight = 236.267 g/mol
| smiles = O=C1NC(=O)NC(=O)C1(/C2=C/CCCC2)CC
| InChI = 1/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17)
| InChIKey = WTYGAUXICFETTC-UHFFFAOYAC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WTYGAUXICFETTC-UHFFFAOYSA-N
}}
}}
'''Cyclobarbital''', also known as '''cyclobarbitol''' or '''cyclobarbitone''', is a [[drug]] which is a [[barbiturate]] [[derivative (chemistry)|derivative]].  
              __NOTOC__
{{SI}}
{{CMG}}
 
==Overview==
   
'''Cyclobarbital''', also known as '''cyclobarbitol''' or '''cyclobarbitone''', is a [[drug]] which is a [[barbiturate]] [[derivative (chemistry)|derivative]].<ref>{{cite pmid|989475}}</ref> It is primarily available in fixed-dose combination with [[diazepam]] under the brand name '''Reladorm''' (100 mg cyclobarbital + 10 mg diazepam) and is used to treat [[insomnia]] in Russia.
 
==References==
{{reflist|2}}
 


{{barbiturates}}
{{Hypnotics and sedatives}}
{{Hypnotics and sedatives}}
[[Category:Barbiturates]]
[[Category:Sedatives]]




{{pharma-stub}}
[[Category:Barbiturates]]
 
[[Category:Drug]]
[[de:Cyclobarbital]]
[[sv:Cyklobarbital]]

Latest revision as of 13:40, 13 April 2015

Cyclobarbital
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H16N2O3
Molar mass236.267 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Cyclobarbital

Articles

Most recent articles on Cyclobarbital

Most cited articles on Cyclobarbital

Review articles on Cyclobarbital

Articles on Cyclobarbital in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cyclobarbital

Images of Cyclobarbital

Photos of Cyclobarbital

Podcasts & MP3s on Cyclobarbital

Videos on Cyclobarbital

Evidence Based Medicine

Cochrane Collaboration on Cyclobarbital

Bandolier on Cyclobarbital

TRIP on Cyclobarbital

Clinical Trials

Ongoing Trials on Cyclobarbital at Clinical Trials.gov

Trial results on Cyclobarbital

Clinical Trials on Cyclobarbital at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cyclobarbital

NICE Guidance on Cyclobarbital

NHS PRODIGY Guidance

FDA on Cyclobarbital

CDC on Cyclobarbital

Books

Books on Cyclobarbital

News

Cyclobarbital in the news

Be alerted to news on Cyclobarbital

News trends on Cyclobarbital

Commentary

Blogs on Cyclobarbital

Definitions

Definitions of Cyclobarbital

Patient Resources / Community

Patient resources on Cyclobarbital

Discussion groups on Cyclobarbital

Patient Handouts on Cyclobarbital

Directions to Hospitals Treating Cyclobarbital

Risk calculators and risk factors for Cyclobarbital

Healthcare Provider Resources

Symptoms of Cyclobarbital

Causes & Risk Factors for Cyclobarbital

Diagnostic studies for Cyclobarbital

Treatment of Cyclobarbital

Continuing Medical Education (CME)

CME Programs on Cyclobarbital

International

Cyclobarbital en Espanol

Cyclobarbital en Francais

Business

Cyclobarbital in the Marketplace

Patents on Cyclobarbital

Experimental / Informatics

List of terms related to Cyclobarbital

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a drug which is a barbiturate derivative.[1] It is primarily available in fixed-dose combination with diazepam under the brand name Reladorm (100 mg cyclobarbital + 10 mg diazepam) and is used to treat insomnia in Russia.

References

  1. PMID 989475 (PMID 989475)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand